Molecular pharmacology of somatostatin receptors

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 350, Issue 5, 1994, Pages 441-453

  Hoyer, Daniel ^a   Lübbert, Hermann ^a   Bruns, Christian ^a  

^a Preclinical Research   (Switzerland)

Author keywords

Molecular cloning; Nomenclature; Pathology; Receptor subtypes; Second messengers; Somatostatin; SRIF

Indexed keywords

ACETYLCHOLINE; ANGIOPEPTIN; BIM 23023; BIM 23027; BIM 23030; BIM 23049; CGP 23996; CYCLO(7 AMINOHEPTANOYLCYSTEINYLPHENYLALANYL DEXTRO TRYPTOPHYLLYSYLTHREONYLCYSTEINE); CYCLO(PROLYLPHENYLALANYL DEXTRO TRYPTOPHYLLYSYLTHREONYLPHENYLALANYL); DEXTRO PHENYLALANYLPHENYLALANYLTYROSYL DEXTRO TRYPTOPHYLLYSYLVALYLPHENYLALANYL DEXTRO [3 (2 NAPHTHYL)ALANINAMIDE]; DEXTRO PHENYLALANYLPHENYLALANYLTYROSYL DEXTRO TRYPTOPHYLLYSYLVALYLPHENYLALANYLTHREONINAMIDE; DOPAMINE; GLUCAGON; GROWTH HORMONE; INSULIN; L 363572; N ACETYLSOMATOSTATIN AMIDE[1 DEALANINE 2 DEGLYCINE 6 (4 CHLOROPHENYLALANINE) 8 DEXTRO TRYPTOPHAN]; NEUROPEPTIDE; RECEPTOR SUBTYPE; SEGLITIDE; SEROTONIN; SOMATOSTATIN; SOMATOSTATIN 14; SOMATOSTATIN 28; SOMATOSTATIN DERIVATIVE; SOMATOSTATIN RECEPTOR; SOMATOSTATIN RECEPTOR ANTAGONIST; UNCLASSIFIED DRUG; UNINDEXED DRUG; VAPREOTIDE;

AUTORADIOGRAPHY; BEHAVIOR; BRAIN; CANCER INHIBITION; CARDIOVASCULAR SYSTEM; COGNITION; GASTROINTESTINAL TRACT; HORMONE RELEASE; HUMAN; MOLECULAR CLONING; NEUROTRANSMITTER RELEASE; NOMENCLATURE; NONHUMAN; REVIEW; SECOND MESSENGER; TISSUE DISTRIBUTION;

AMINO ACID SEQUENCE; ANIMAL; CLONING, MOLECULAR; HUMAN; MOLECULAR SEQUENCE DATA; RECEPTORS, SOMATOSTATIN; SECOND MESSENGER SYSTEMS; SOMATOSTATIN; TERMINOLOGY; TRANSCRIPTION, GENETIC;

EID: 0028032277     PISSN: 00281298     EISSN: 14321912     Source Type: Journal    
DOI: 10.1007/BF00173012     Document Type: Review

References (152)

1. CSF somatostatin in obsessive-compulsive disorder
2. Evidence that somatostatin enhances endogenous acetylcholine release in the rat hippocampus
3. Somatostatin and cholecystokinin octapeptide differentially modulate the release of [3H] acetylcholine from caudate nucleus but not cerebral cortex: role of dopamine receptor activation
4. Somatostatin and muscarinic inhibition of canine enteric endocrine cells: cellular mechanisms
5. β-Adrenergic and somatostatin receptors regulate Na-H exchange independent of cAMP
6. SMS 201-995: A very potent and selective octapeptide analogue of somatostatin with prolonged action
7. Widespread reduction of somatostatin-like immunoreactivity in the cerebral cortex in Alzheimer's disease
8. Molecular biology of somatostatin receptors
9. Somatostatin in Alzheimer's disease and depression
10. In vitro release of somatostatin from cerebral cortical slices: characterization of electrically evoked release
11. Hypothalamic polypeptide that inhibits secretion on immunoreactive pituitary growth hormone
12. Molecular cloning and functional expression of a brain-specific somatostatin receptor
13. Tissue distribution of somatostatin receptor subtype messenger ribonucleic acid in the rat
14. Identification and characterization of somatostatin receptors in neonatal rat long bones
15. Human somatostatin receptor hSSTR2 may mediate the antiproliferative effect of octreotide
16. Stimulatiom of tyrosine phosphatase and inhibition of cell proliferation by somatostatin analogues: mediation by human somatostatin receptor subtypes SSTR1 and SSTR2
17. Synthesis and biological activity of highly potent octapeptide analogs of somatostatin
18. Somatostatin regulates dopamine release in rat stratal slices and cat caudate nucleus
19. Vasoactive intestinal polypeptide receptors linked to an adenylate cyclase, and their relationship with biogenic amine- and somatostatin-sensitive adenylate cyclases on central neuronal and glial cells in primary cultures
20. Somatostatin inhibits adrenergic and cholinergic neurotransmission in smooth muscle
21. A human somatostatin receptor (SSTR3), located on chromosome 22, displays preferential affinity for somatostatin-14 like peptides
22. Somatostatin receptor binding in rat cerebral cortex
23. Decreased somatostatin immunoreactivity but not neuropeptide Y immunoreactivity in cerebral cortex in senile dementia of Alzheimer type
24. Cloning and expression of a human somatostatin-14-selective receptor variant (somatostatin receptor 4) located on chromosome 20
25. Cysteamine-induced depletion of somatostatin produces differential cognitive deficits in rats
26. Regulation of ATP-sensitive K+ channels in insulinoma cells: activation by somatostatin and protein kinase C and the role of cAMP
27. Antagonist effects of seglitide (MK 678) at somatostatin receptors in guinea-pig isolated right atria
28. Somatostatin inhibits basal and vasoactive intestinal polypeptide stimulated hormone release by different mechanisms in GH pituitary cells
29. Somatostatin in the central nervous system: physiological and pathological modifications
30. Localization and quantification of somatostatin receptors by light microscopic autoradiography
31. Autoradiographic localization of a non-reducible somatostatin analog (125I-CGP-23996) binding sites in the rat brain: Comparison with membrane binding
32. The anterior periventricular hypothalamus is the site of somatostatin inhibition on its own release: An in vitro and immunohistochemical study
33. Somatostatin receptors on pituitary somatotrophs, thyrotrophs, and lactotrophs: pharmacological evidence for loose coupling to adenylate cyclase
34. Purification of a pituitary receptor for somatostatin: The utility of biotinylated somatostatin analogs
35. Long-lasting antinociceptive effect of RC-160, a somatostatin analog, in mice and rats
36. Somatostatin and analogs in the treatment of cancer
37. Characterization of somatostatin receptors in guinea-pig isolated ileum, vas deferens and right atrium
38. Somatostatin activates glibenclamide-sensitive and ATP-regulated K+ channels in insulinoma cells via a G-protein
39. Somatostatin antagonist analog increases GH, insulin, and glucagon release in the rat
40. Transient expression of somatostatin receptors in the rat cerebellum during development
41. Somatostatin selectively inhibits noradrenaline release from hypothalamic neurones
42. Cysteamine-induced depletion of central SRIF-like immunoreactivity: effects on behavior, learning, memory and brain neurochemistry
43. Differential binding of somatostatin agonists to somatostatin receptors in brain and adenohypophysis
44. International Union of Pharmacology Classification of receptors for 5-hydroxytryptamine (serotonin)
45. Pharmacological identity between somatostatin SS-1/SS-2 sites and SSTR-2/SSTR-1 receptors, respectively
46. A proposed new nomenclature for 5-HT receptors
47. Somatostatin cyclic octapeptide analogs which preferentially bind to SOMa receptors block a calcium current in rat superior cervical ganglion neurons
48. Somatostatin induces an inward rectification in rat locus coeruleus neurones through a pertussis toxin-sensitive mechanism
49. Somatostatin analogues inhibit somatostatin relase
50. Calcium-dependent release of somatostatin and neurotensin from rat brain in vitro
51. A nucleotide regulatory site for somatostatin inhibition of adenylate cyclase in S49 lymphoma cells
52. mRNA distribution and second messenger coupling of four somatostatin receptors expressed in the brain
53. Definition of pharmacological receptors
54. Assignment of G-protein subtypes to specific receptors inducing inhibition of calcium currents
55. Different β-subunits determine G-protein interaction with transmembrane receptors
56. Selectivity in signal transduction determined by γ-subunits of heterotrimeric G-proteins
57. Expression cloning of a rat brain somatostatin receptor cDNA
58. The somatostatin receptor is directly coupled to adenylate cyclase in GH4C1 pituitary cell membranes
59. Differential expression of messenger RNAs for somatostatin receptor subtypes SSTR1, SSTR2, SSTR3 in adult rat brain: analysis by RNA blotting and in situ hybridization histochemistry
60. Calcitonin gene-related peptide stimulates rat gastric somatostatin release in vitro
61. Parallel in vivo and in vitro detection of functional somatostatin receptors in human endocrine pancreatic tumors: Consequences with regard to diagnosis, localization and therapy
62. The role of somatostatin and its analogs in the diagnosis and treatment of tumors
63. Agonist binding to rat brain somatostatin receptors alters the interaction of the receptors with guanine nucleotide-binding regulatory proteins
64. Identification of the subunits of GTP-binding proteins coupled to somatostatin receptors
65. Giα3 and Goα selectively associate with the cloned somatostatin receptor SSTR2
66. Localization and characterization of brain somatostatin receptors as studied with somatostatin-14 and somatostatin-28 receptor autoradiography
67. The somatostatin receptor in the GI tract
68. A guanine nucleotide-binding protein mediates the inhibition of voltage-dependent calcium current by somatostatin in a pituitary cell line
69. Cloning and expression of a rat somatostatin receptor enriched in brain
70. Differential effects of somatostatin on adenylate cyclase as functional correlate for different brain somatostatin receptor subpopulations
71. Huntington's disease is accompanied by changes in the distribution of somatostatin-containing neuronal processes
72. Differential distribution of somatostatin receptor subtypes in rat brain revealed by newly developed somatostatin analogs
73. The effects of cysteamine on dopamine-mediated behaviors: evidence for dopamine-somatostatin interactions in the striatum
74. Brain somatostatin receptor subpopulation visualized by autoradiography
75. release of [3Effects of somatostatin-14 on the in vitroH]GABA from slices of rat caudate putamen
76. Molecular cloning of a somatostatin-28 receptor and comparison of its expression pattern with that of a somatostatin-14 receptor in rat brain
77. Use of the mouse vas deferens assay to evaluate the action of somatostatin peptides on gastric acid secretion
78. Somatostatin increases an inwardly rectifying potassium conductance in guineapig submucous plexus neurones
79. Somatostatin augments the M-current in hippocampal neurons
80. Effect of somatostatin on acetylcholine release from rat hippocampal synaptosomes
81. Molecular cloning and expression of a pituitary somatostatin receptor with preferential affinity for somatostatin-28
82. Somatostatin and somatostatin-like peptides: Clinical research and clinical applications
83. Reduced density of somatostatin receptors in Huntington's chorea
84. Somatostatin mediation of adenohypophysial secrretion
85. Multiple gene transcripts of the somatostatin receptor SSTR2: tissue selective distribution and cAMP regulation
86. All five cloned human somatostatin receptors (hSSTR1–5) are functionally coupled to adenylyl cyclase
87. Localisation of somatostatin (SRIF) SSTR-1, SSTR-2 and SSTR-3 receptor mRNA in rat brain by in situ hybridization
88. The inhibitory effect of somatostatin peptides on the rat anococcygeus muscle in vitro
89. An analysis of the negative inotropic action of somatostatin
90. Analogs of somatostatin selectively label distinct subtypes of somatostatin receptors in rat brain
91. Subtypes of brain somatostatin receptors couple to multiple cellular effector systems
92. Cloned somatostatin Receptors: Identification of subtype-selective peptides and demonstration of high affinity binding of linear peptides
93. Characterization of cloned somatostatin receptors
94. Somatostatin receptors in the nucleus accumbens selectively mediate the stimulatory effect of somatostatin on locomotor activity in rats
95. Somatostatin
96. Cellular mechanisms of somatostatin inhibition of calcium influx in the anterior pituitary cell line AtT-20
97. Pertussis toxin treatment blocks the inhibition of somatostatin and increases stimulation by forskolin of cAMP accumulation and adrenocorticotropin secretion from mouse anterior pituitary cells
98. Splice variant of the somatostatin receptor 2 subtype, SSTR2B, couples to adenylyl cyclase
99. Pharmacological properties of two cloned somatostatin receptors
100. Evidence for two somatostatin-14 receptor types in rat brain cortex
101. New specific radioligand for one subpopulation of brain somatostatin receptors
102. Autoradiographic mapping of somatostatin receptors in the rat central nervous system and pituitary
103. Different ionic requirements for somatostatin receptor subpopulations in the brain
104. High affinity binding sites for somatostatin to rat pituitary
105. Specific high affinity binding sites for somatostatin-28 on pancreatic β-cells: differences with brain somatostatin receptors
106. Distribution of somatostatin receptors in the human brain: an autoradiographic study
107. Distinct topographical localization of two somatostatin receptor subpopulations in the human cortex
108. In vitro detection of somatostatin receptors in human tumors
109. D-Trp-8-somatostatin: an analog of somatostatin more potent than the native molecule
110. Somatostatin release from cerebral cortical cells: influence of amino acid neurotransmitters
111. Cloning and characterisation of a novel human somatostatin receptor
112. Cyclic AMP-independent dual regulation of voltage-dependent Ca2+ currents by LHRH and somatostatin in a pituitary cell line
113. Characterization of functional receptors for somatostatin in rat pituitary cells in culture
114. Somatostatin inhibition of hippocampal CAI pyramidal neurons: mediation by arachidonic acid and its metabolites
115. Somatostatin activates an inwardly rectifying K+ conductance in freshly dispersed rat somatotrophs
116. Somatostatin receptors: Identification and characterization in rat membranes
117. Somatostatin Analogs. Dissociation of brain receptor binding affinities and pituitary actions in the rat
118. Receptor binding of somatostatin-28 is tissue specific
119. Somatostatin receptors on rat pancreatic acinar cells
120. Somatostatin receptor: evidence for structural and functional heterogeneity
121. The rat SSTR2 somatostatin receptor subtype is coupled to inhibition of cyclic AMP accumulation
122. Somatostatin facilitates the serotonin release form rat cerebral cortex, hippocampus and hypothalamus slices
123. Glutamate stimulates somatostatin release from diencephalic neurons in primary culture
124. Pharmacological properties of the NMDA receptor involved in somatostatin release from cortical neurons
125. Somatostatin receptor subtypes in the clonal anterior pituitary cell lines AtT-20 and GH3
126. Two types of somatostatin receptors differentiated by cyclic somatostatin analogs
127. Somatostatin receptors: distribution in rat central nervous system and human frontal cortex
128. Neuropeptides and neuropathology in the amygdala in Alzheimer's disease: relationship between somatostatin, neuropeptide Y and subregional distribution of neuritic plaques
129. Effects of somatostatin on the secretion of thyrotropin and prolactin
130. Cloning and expression of a novel mouse somatostatin receptor (SSTR2B)
131. The two isoforms of the mouse somatostatin receptor (mSSTR2A and mSSTR2B) differ in coupling efficiency to adenylate cyclase and agonist-induced receptor desensitization
132. Highly active cyclic and bicyclic somatostatin analogues of reduced ring size
133. A potent cyclic hexapeptide analogue of somatostatin
134. Preclinical and clinical studies with somatostatin related to the central nervous system
135. A peptidase resistant cyclic octapeptide analogue of somatostatin (SMS 201-995) modulates seizures induced by quinolinic and kainic acids differentially in the rat hippocampus
136. Somatostatin release is enhanced in the hippocampus of partially and fully kindled rats
137. Extracellular somatostatin measured by microdialysis in the hippocampus of freely moving rats: evidence for neuronal release
138. Functional somatostatin receptors on a rat pancreatic acinar cell line
139. Somatostatin-14 and somatostatin-28 induce opposite effects on potassium currents in rat neocortical neurons
140. Lack of cross-desensizization of somatostatin-14 and somatostatin-28 receptors coupled to potassium channels in rat neocortical neurons
141. Pharmacological evidence that somatostatin activates the M-current in hippocampal pyramidal neurons
142. Somatostatin stimulates Ca2+-activated K+ channels through protein dephosphorylation
143. Expression patterns of rat somatostatin receptor genes in pre- and postnatal brain and pituitary
144. Molecular cloning and sequencing of a human somatostatin receptor, hSSTR4
145. Cloning and functional characterization of a family of human and mouse somatostatin receptors expressed in brain, gastrointestinal tract, and kidney
146. Somatostatin receptors, an expanding gene family: Cloning and functional characterization of human SSTR3, a protein coupled to adenylyl cyclase
147. Human somatostatin receptor genes: localization to human chromosomes 14, 17 and 22 and identification of simple tandem repeat polymorphisms
148. Cloning, functional expression and pharmacological characterization of a fourth (hSSTR4) and fifth (hSSTR5) human somatostatin receptor subtype
149. Cloning of a novel somatostatin receptor, SSTR3, coupled to adenylylcyclase
150. Reconstitution of somatostatin and muscarinic receptor mediated stimulation of K+ channels by isolated Gk protein in clonal rat anterior pituitary cell membranes